Clinical Trials · NCT03641560
A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 52
- Start date
- Sep 2018
- Locations
- 8 sites, India
- Primary endpoint
- Number of Participants With Treatment- Emergent Adverse Events (TEAEs)